Dr. Jeruss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
- McGaw Medical Center of Northwestern UniversityResidency, Surgery, 1997 - 2005
- University of Vermont College of MedicineClass of 1997
Certifications & Licensure
- MI State Medical License 2014 - 2027
- IL State Medical License 1997 - 2017
- TX State Medical License 2005 - 2006
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence Start of enrollment: 2011 Nov 01
Publications & Presentations
PubMed
- Psychological Considerations Associated with Lobular Breast Cancer.Jasmine C Walker, Shivali Patel, Erin F Cobain, Celina G Kleer, Colleen H Neal
Current Psychiatry Reports. 2024-12-17 - Design Principles of an Engineered Metastatic Niche for Monitoring of Cancer Progression.Guillermo Escalona, Ramon Ocadiz-Ruiz, Jeffrey A Ma, Ian A Schrack, Brian C Ross
Biotechnology and Bioengineering. 2024-12-03 - Engineered Immunologic Niche Monitors Checkpoint Blockade Response and Probes Mechanisms of Resistance.Ravi M Raghani, Russell R Urie, Jeffrey A Ma, Guillermo Escalona, Ian A Schrack
Immunomedicine. 2024-06-01
Press Mentions
- New Tests and Devices for Early Cancer DetectionApril 1st, 2020
- Drug Combo Gangs up to Take on Triple-Negative Breast CancerOctober 25th, 2017
- Pink Beer on Tap as Ann Arbor Businesses Support Breast Cancer CampaignOctober 18th, 2017
- Join now to see all
Grant Support
- The Oncogenic Significance Of Cyclin Overexpression And SMAD 3 Tumor SuppressionNational Cancer Institute2011
- The Oncogenic Significance Of Cyclin Overexpression And SMAD 3 Tumor SuppressionNational Cancer Institute2010
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: